The highest profile issue that Ley had to confront was sodium cyclamate.
In September 1982, interviewed for the oral history program of the FDA History Office, Maurice D. Kinslow, Chairman of the committee and author of the final draft of the July 1969 "Kinslow report" characterized Dr. Ley as Commissioner : "Since I reported to him [Dr.